SCHEMBL26643452

SCHEMBL26643452

COc1cc(Br)nc(/C=N/O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 1/20 0.54
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ALOX15 P16050 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ APP P05067 1/20 0.35
▸ HPGD P15428 4/20 0.34
▸ HTT P42858 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ MAPK1 P28482 2/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MEN1 O00255 2/20 0.33
▸ GFER P55789 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ FGF23 Q9GZV9 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31322979 1.00 HSP90AA1 (0.54) HSP90AA1KMT2AKDM4EL3MBTL1ALOX15
SCHEMBL26644028 0.77 MAPT (0.39) KMT2AKDM4EL3MBTL1ALDH1A1APP
SCHEMBL26644345 0.77 GAA (0.38) HSP90AA1KDM4EL3MBTL1ALOX15ALDH1A1
SCHEMBL26643704 0.77 GAA (0.38) HSP90AA1KDM4EL3MBTL1ALOX15ALDH1A1
SCHEMBL30644443 0.77 GAA (0.38) HSP90AA1KDM4EL3MBTL1ALOX15ALDH1A1
SCHEMBL1425697 0.77 ALDH1A1 (0.37) HSP90AA1KMT2AL3MBTL1ALDH1A1APP
SCHEMBL30644442 0.77 MAPT (0.39) KMT2AKDM4EL3MBTL1ALDH1A1APP
SCHEMBL30644472 0.77 ALDH1A1 (0.37) HSP90AA1KMT2AL3MBTL1ALDH1A1APP
SCHEMBL1424963 0.74 ALDH1A1 (0.53) KMT2AKDM4EL3MBTL1ALDH1A1HPGD
SCHEMBL11016671 0.73 HSP90AA1 (0.73) HSP90AA1KMT2AKDM4EL3MBTL1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250282768-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2025-09-11 — — US disclosed
EP-4522607-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF-kB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2025-03-19 — — EP disclosed
WO-2023217851-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF-κB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2023-11-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250282768-A1 PYRROLIDINONE DERIVATIVES AS INHIBITORS OF NF KAPPA B INDUCING KINASE NFKBIA, IKBKG, IKBKB HSP90AA1 2033/4885KMT2A 2954/4885KDM4E 1412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback